The rise of the balloon: drug eluting balloons show great promise in treating arterial disease
This article was originally published in Clinica
Executive Summary
Drug-coated balloon catheters have great potential in coronary intervention, having several safety advantages over the standard products used, drug-coated stents. To allow this new technology to fulfil its promise, a consistent regulatory framework is necessary, writes Tim Clay, head of market strategy at Cambridge Consultants.